Tufts University School of Dental Medicine
Boston, Massachusetts, 02111, United States
NCT Number: NCT06194123
The objective of this study is to evaluate how well the study product, Crest Daily Whitening Serum, alleviates Xerostomia and perceived halitosis over 1 week of use.
This study is active but is not currently recruiting participants.
Notify Me18 year and older
All sexes
Interventional
Not applicable
Boston, Massachusetts, 02111, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
i. Subjects who are currently pregnant (self-reported). ii. Unstimulated salivary flow rate of more than 0.18mL/min iii. Subjects that have ever received therapeutic radiation in the head and neck area.
iv. Subjects with a diagnosis of conditions that would affect salivary flow such as Sjogren's Syndrome per the investigator's expert opinion.
v. Subjects with a condition the investigator believes not suitable for the study, such as autoimmune diseases and radiation therapy to head and neck region that impact salivary flow.
vi. Subjects that currently use whitening toothpaste, desensitizing toothpaste, or any other products causing similar results.
vii. Subjects currently participating in any other research studies. viii. Subject unable to provide consent (e.g. Cognitively impaired adults). ix. Non-English speaking
one week's use of Crest Daily Whitening Serum as described on the label.
Time frame: 5, 30, 60 minute post application of product as well as degree of change after a 7 day period of use.
To observe presence and degree of reduction in the self-reported subjective perception of dryness in the oral cavity at different time intervals after the application of a Whitening Agent with Emulsion Gel in Xerostomic Population
Time frame: 60 minutes post application as well as degree of change after a 7 day period of use.
To measure presence and degree of reduction of self-reported bad breath and subject's objective measurement of how well saliva production improved on a 1-10 scale at different time intervals with a Whitening Agent with Emulsion Gel in Xerostomic Population
Tufts University
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05820711
Head and Neck Cancer, Head and Neck Neoplasms
Madison, Wisconsin, United States
View Trial DetailsNCT06365047
Mouth Diseases, Salivary Gland Diseases
Boston, Massachusetts, United States
View Trial DetailsNCT07394842
Carcinoma, Carcinoma, Squamous Cell
Cairo, Egypt
View Trial DetailsNCT06877546
Arthritis, Arthritis, Rheumatoid
Helsinki, Finland
View Trial Details